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Is the Cefoxitin Disk Test Reliable Enough To Detect Oxacillin Resistance in
Coagulase-Negative Staphylococci?
Coagulase-negative staphylococci (CoNS) represent an im-
portant etiology of nosocomial bloodstream infections (2, 4, 6).
The introduction of empirical treatment has been a crucial step
in reducing morbidity and mortality caused by such infections
and in controlling the spread of resistant strains (1, 6). It has
been advocated that the cefoxitin disk would be more sensitive
than the 1-g oxacillin disk to predict the oxacillin heterore-
sistance phenotype among staphylococci (1, 2, 4, 7, 8). Thus,
the National Committee for Clinical Laboratory Standards
(NCCLS) has recommended its use for detection of oxacillin
resistance (7). A total of 5 of 241 (2.2%) CoNS displaying
cefoxitin inhibition zones of 25 mm and resistance to oxacil-
lin by disk diffusion test were isolated by the clinical laboratory
of the Hospital Sa˜o Paulo, a tertiary university hospital located
in Sa˜o Paulo, Brazil, during September and October 2004. The
bacterial strains were isolated from diverse body sites and
referred to the Laborato´rio Especial de Microbiologia Clı´nica
of Universidade Federal de Sa˜o Paulo for further character-
ization. The identification of the CoNS was confirmed based
on the morphology of bacterial colonies on blood agar, Gram
stain, 3% H2O2 catalase and by agglutination tests (Staphy-
test; PROBAC, Sa˜o Paulo, Brazil). The strains were tested for
coagulase activity by slide tests with rabbit plasma (Difco Lab-
oratories, Detroit, MI). The final identification was carried out
using the GPI card Vitek (BioMerieux, Hazelwood, MI). The
antimicrobial susceptibility testing of six antimicrobial agents
was performed using Etest (AB Biodisk, Solna, Sweden). The
results were interpreted according to the NCCLS guidelines
(7). Staphylococcus aureus ATCC 25923 and ATCC 29213 were
used as quality control strains. The mecA gene was detected by
PCR technique according to the method described previously
(6). The genetic relatedness of the five CoNS was evaluated by
automated ribotyping using the RiboPrinter microbial charac-
terization system (Qualicon, Wilmington, DE). Isolates were
considered to belong to the same ribogroup if their similarity
coefficients were 0.93. According to the Vitek system, all five
isolates were identified as Staphylococcus epidermidis. They
were susceptible to linezolid, vancomycin, and teicoplanin.
These isolates were confirmed to be resistant to oxacillin and
exhibited cefoxitin inhibition zones that were 25 mm, as
shown in Table 1. The presence of the mecA gene was detected
in all five CoNS, which displayed distinct ribotyping patterns.
Oxacillin resistance among staphylococci is caused by ex-
pression of penicillin-binding protein 2a (PBP2a), encoded by
the mecA gene, which has low binding affinity to all beta-lactam
antibiotics available in the clinical practice (1, 2, 3, 4, 5, 9).
Detection of oxacillin resistance is complicated because dis-
tinct populations of staphylococci express different levels of
resistance. Cefoxitin is considered to be a better predictor than
oxacillin for the detection of oxacillin heteroresistance because
it is a stronger inducer of PBP2a. In addition, it has high affinity
for staphylococcal PBP4, and previous experiments have
shown a relationship between PBP2, PBP4, and methicillin
resistance (2, 4). Many studies have reported that cefoxitin
disks had high sensitivities (97.0 to 100.0%) and specificities
(99.0 to 100.0%) in detecting heterogeneous populations of
oxacillin-resistant staphylococci (2, 4, 9). However, we ob-
served discrepant results between oxacillin and cefoxitin disks
when testing CoNS by disk diffusion. Initially, it was thought
these CoNS did not belong to S. epidermidis species and did
not carry the mecA gene since they had low oxacillin MICs.
However, the Vitek system identified these isolates as S. epi-
dermidis, and the presence of the mecA gene was confirmed by
PCR in all isolates. The chance of clonality was also discarded,
since no genetic relatedness was encountered among the
CoNS, refuting the possibility of an outbreak caused by a strain
exhibiting an unusual phenotype. In the absence of a national
guideline, most of the Brazilian laboratories follow the NCCLS
recommendations. In addition, dilution tests are not available
at most Brazilian laboratories, and disk diffusion has been the
most performed susceptibility technique. If the cefoxitin results
were considered instead of the oxacillin results, these CoNS
would have been falsely reported as susceptible to oxacillin,
with direct implications for the choice of drugs for treatment.
Although the number of isolates tested was low in this study,
our results show that the detection of low-level methicillin
resistance by the cefoxitin disk among CoNS can be problem-
atic. Thus, our results highlight the importance of testing the
oxacillin disk or using molecular techniques for detection of
the mecA gene (1, 3, 6, 9). Moreover, changes in the NCCLS
cefoxitin disk diffusion breakpoints could be useful for screen-
ing such isolates, since all CoNS tested had cefoxitin zones of
inhibition between 26 and 29 mm. To increase the sensitivity
and specificity of the cefoxitin disk to detect oxacillin hetero-
resistance among S. aureus, other authors have also suggested
changes in the interpretative zone diameters of cefoxitin (4, 9).
TABLE 1. Species identifications, antimicrobial susceptibility profiles, ribotyping patterns, and detection of mecA gene among
CoNS recently isolated at Hospital Sa˜o Paulo, Sa˜o Paulo, Brazil
Bacterial
strain Vitek identity
Disk diffusion
zones (mm) MIC (g/ml)
a
Ribogroup mecA gene
OXAb CFX OXA VAN TP LZ LEV TMP-SMX
438308 S. epidermidis 10 26 2.0 1.5 2.0 0.38 1.5 0.50 145-5 Positive
413321 S. epidermidis 10 26 2.0 2.0 3.0 0.50 16.0 3.0 154-6 Positive
370018 S. epidermidis 12 29 1.0 3.0 2.0 0.38 0.094 0.19 154-3 Positive
420689 S. epidermidis 12 27 1.5 1.5 4.0 0.75 0.125 32.0 154-4 Positive
420387 S. epidermidis 10 26 1.5 1.5 3.0 0.50 2.0 0.064 154-5 Positive
a Determined by Etest (Solna, Sweden).
b CFX, cefoxitin; LEV, levofloxacin; LZ, linezolid; OXA, oxacillin; TP, teicoplanin; VAN, vancomycin; TMP-SMX, trimethoprim-sulfamethoxazole.
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